SCHEMBL7079926

SCHEMBL7079926

Nc1cccc(CCc2ccc(S(=O)(=O)CC(CC(=O)O)c3ccccc3)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.48
MAOB P27338 2/20 0.48
CYP19A1 P11511 1/20 0.43
GABBR2 O75899 1/20 0.42
GABBR1 Q9UBS5 1/20 0.42
PRMT1 Q99873 1/20 0.40
F10 P00742 1/20 0.40
MMP2 P08253 3/20 0.40
MMP9 P14780 3/20 0.40
MMP8 P22894 3/20 0.40
MMP1 P03956 2/20 0.40
MMP3 P08254 2/20 0.40
NAMPT P43490 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
ALDH1A1 P00352 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7077874 0.88 F2 (0.46) MAOAMAOBCYP19A1PRMT1F10
SCHEMBL10279296 0.82 CA12 (0.40) GABBR2GABBR1F10MMP2MMP9
SCHEMBL7073687 0.81 GABRP (0.43) GABBR2GABBR1F10MMP2MMP9
SCHEMBL7080823 0.79 GABBR2 (0.49) GABBR2GABBR1PRMT1MMP2ALDH1A1
SCHEMBL7080988 0.79 ITGB3 (0.44) CA1CA2CA9ALDH1A1ATM
SCHEMBL8909238 0.78 GABBR2 (0.56) GABBR2GABBR1MMP2ALDH1A1ATM
SCHEMBL7130131 0.78 ITGB3 (0.46) MMP2MMP9MMP8MMP1MMP3
SCHEMBL7133113 0.77 MEN1 (0.47) GABBR2GABBR1PRMT1MMP2MMP9
SCHEMBL7080966 0.77 KDR (0.47) ALDH1A1ATM
SCHEMBL7073753 0.76 GABBR2 (0.50) GABBR2GABBR1MMP2CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059872-A1 AVB3 AND AVB5 INTEGRIN ANTAGONISTS AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH AVB3 AND AVB5 INTEGRINS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-24 WO disclosed